Search Results - César O. Freytes

Refine Results
  1. 1
    Transplantation of CD34+ peripheral blood progenitor cells after high- dose chemotherapy for patients with advanced multiple myeloma

    Transplantation of CD34+ peripheral blood progenitor cells after high- dose chemotherapy for patients with advanced multiple myeloma by Gary J. Schiller, Robert Vescio, César O. Freytes, Gary Spitzer, Firoozeh Sahebi, M Lee, C-H. Wu, Jiang Cao, JC Lee, CH Hong

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Allogeneic versus autologous stem cell transplantation after relapsing following first line autologous transplantation for multiple myeloma: A systematic review

    Allogeneic versus autologous stem cell transplantation after relapsing following first line autologous transplantation for multiple myeloma: A systematic review by Heinz Ludwig, Sarah Bernhard, Takashi Ikeda, César O. Freytes, Martin Schreder, Koji Kawamura, Yoshiko Atsuta, Hiroyuki Takamatsu, David H. Vesole, Parameswaran Hari, Julie Krainer, Axel Hinke

    Published 2025
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation

    Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation by César O. Freytes, David H. Vesole, J Le-Rademacher, Xiaobo Zhong, Robert Peter Gale, RA Kyle, Donna Reece, J. N. Alastair Gibson, Harry C. Schouten, Phillip McCarthy, Sagar Lonial, A. Krishnan, Angela Dispenzieri, Parameswaran Hari

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Survival Improvements in Adolescents and Young Adults after Myeloablative Allogeneic Transplantation for Acute Lymphoblastic Leukemia

    Survival Improvements in Adolescents and Young Adults after Myeloablative Allogeneic Transplantation for Acute Lymphoblastic Leukemia by William A. Wood, Stephanie J. Lee, Ruta Brazauskas, Zhiwei Wang, Mahmoud Aljurf, Karen K. Ballen, David Buchbinder, Jason Dehn, César O. Freytes, Hillard M. Lazarus, Charles F. LeMaistre, Paulette Mehta, David Szwajcer, Steven Joffe, Navneet S. Majhail

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma

    Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma by Marcel P. Devetten, Parameswaran Hari, Jeanette Carreras, Brent R. Logan, Koen van Besien, Christopher Bredeson, César O. Freytes, Robert Peter Gale, John Gibson, Sergio Giralt, Steven C. Goldstein, Vikas Gupta, David I. Marks, Richard T. Maziarz, Julie M. Vose, Hillard M. Lazarus, Paolo Anderlini

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome

    Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome by Mary Jo Lechowicz, Hillard M. Lazarus, Joaquim Carreras, Ginna G. Laport, Corey Cutler, Peter H. Wiernik, Gregory A. Hale, Dipnarine Maharaj, Robert Peter Gale, Philip A. Rowlings, César O. Freytes, Alan M. Miller, Julie M. Vose, Richard T. Maziarz, Silvia Montoto, DG Maloney, Parameswaran Hari

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Hospital Length of Stay in the First 100 Days after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia in Remission: Comparison among Alternative Graft Sources

    Hospital Length of Stay in the First 100 Days after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia in Remission: Comparison among Alternative Graft Sources by Karen K. Ballen, Steven Joffe, Ruta Brazauskas, Zhiwei Wang, Mahmoud Aljurf, Görgün Akpek, Christopher E. Dandoy, Haydar Frangoul, César O. Freytes, Nandita Khera, Hillard M. Lazarus, Charles F. LeMaistre, Paulette Mehta, Susan K. Parsons, David Szwajcer, Celalettin Üstün, William A. Wood, Navneet S. Majhail

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma

    Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma by Olle Ringdén, Sudeep Shrestha, Gisela Tunes da Silva, M-J Zhang, Angela Dispenzieri, Mats Remberger, Ravindra R. Kamble, César O. Freytes, Gale Rp, John Gibson, Vikas Gupta, Leona Holmberg, Hillard Lazarus, Philip L. McCarthy, Katie Meehan, Harry C. Schouten, Giuseppe Milone, Sagar Lonial, Parameswaran Hari

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy

    Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy by Narendranath Epperla, Ang Li, Brent R. Logan, Caitrin Fretham, Saurabh Chhabra, Mahmoud Aljurf, Lynette Chee, Edward A. Copelan, César O. Freytes, Peiman Hematti, Hillard M. Lazarus, Mark R. Litzow, Taiga Nishihori, Richard F. Olsson, Tim Prestidge, Wael Saber, Baldeep Wirk, Jean A. Yared, Alison W. Loren, Marcelo C. Pasquini

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Impact of Pretransplant Therapy and Depth of Disease Response before Autologous Transplantation for Multiple Myeloma

    Impact of Pretransplant Therapy and Depth of Disease Response before Autologous Transplantation for Multiple Myeloma by Ravi Vij, Shaji Kumar, Mei-Jie Zhang, Xiaobo Zhong, Jiaxing Huang, Angela Dispenzieri, Muneer H. Abidi, Jennifer M. Bird, César O. Freytes, Robert Peter Gale, Tamila L. Kindwall‐Keller, Robert A. Kyle, Daniel J. Landsburg, Hillard M. Lazarus, Reinhold Munker, Vivek Roy, Manish Sharma, Dan T. Vogl, Baldeep Wirk, Parameswaran Hari

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    The Graft-Versus-Myeloma Effect Using Non-Myeloablative Or Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

    The Graft-Versus-Myeloma Effect Using Non-Myeloablative Or Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) by Olle Ringdén, John Barrett, Sudeep Shrestha, da Silva G. Tunes, M.-J. Zhang, Angela Dispenzieri, Mats Remberger, Ravindra R. Kamble, César O. Freytes, Robert Peter Gale, John Gibson, Vikas Gupta, Leona Holmberg, Hillard M. Lazarus, Philip L. McCarthy, Katie Meehan, Harry C. Schouten, Giuseppe Milone, Sagar Lonial, Parameswaran Hari

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Effect of Obesity on Outcomes after Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

    Effect of Obesity on Outcomes after Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma by Dan T. Vogl, Tao Wang, Waleska S. Pérez, Edward A. Stadtmauer, Daniel F. Heitjan, Hillard M. Lazarus, Robert A. Kyle, Ram Kamble, Daniel J. Weisdorf, Vivek Roy, John Gibson, Karen K. Ballen, Leona Holmberg, Asad Bashey, Philip L. McCarthy, César O. Freytes, Dipnarine Maharaj, Ângelo Maiolino, David H. Vesole, Parameswaran Hari

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant

    Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant by Parameswaran Hari, M-J Zhang, Vivek Roy, Waleska S. Pérez, Asad Bashey, Luen Bik To, Gerald J. Elfenbein, César O. Freytes, Robert Peter Gale, John Gibson, Robert A. Kyle, H M Lazarus, Phillip McCarthy, Giuseppe Milone, S Pavlovsky, Donna Reece, Gary J. Schiller, Jorge Vela‐Ojeda, Daniel J. Weisdorf, David H. Vesole

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis

    Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis by Kristjan Paulson, Ruta Brazauskas, Nandita Khera, Naya He, Navneet S. Majhail, Görgün Akpek, Mahmoud Aljurf, David Buchbinder, Linda J. Burns, Sara Beattie, César O. Freytes, Anne Garcia, James Gajewski, Theresa Hahn, Jennifer M. Knight, Charles F. LeMaistre, Hillard M. Lazarus, David Szwajcer, Matthew D. Seftel, Baldeep Wirk, William A. Wood, Wael Saber

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Allogeneic Transplants in Follicular Lymphoma: Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative Conditioning

    Allogeneic Transplants in Follicular Lymphoma: Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative Conditioning by Parameswaran Hari, Jeanette Carreras, Mei-Jie Zhang, Robert Peter Gale, Brian J. Bolwell, Christopher Bredeson, Linda J. Burns, Mitchell S. Cairo, César O. Freytes, Steven C. Goldstein, Gregory A. Hale, David J. Inwards, Charles F. LeMaistre, Dipnarine Maharaj, David I. Marks, Harry C. Schouten, Shimon Slavin, Julie M. Vose, Hillard M. Lazarus, Koen van Besien

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Pediatric‐inspired therapy compared to allografting for <scp>P</scp>hiladelphia chromosome‐negative adult ALL in first complete remission

    Pediatric‐inspired therapy compared to allografting for <scp>P</scp>hiladelphia chromosome‐negative adult ALL in first complete remission by Matthew D. Seftel, Donna Neuberg, Mei‐Jie Zhang, Hai‐Lin Wang, Karen K. Ballen, Julie Bergeron, Stephen Couban, César O. Freytes, Mehdi Hamadani, Mohamed A. Kharfan‐Dabaja, Hillard M. Lazarus, Taiga Nishihori, Kristjan Paulson, Wael Saber, Stephen E. Sallan, Robert J. Soiffer, Martin S. Tallman, Ann E. Woolfrey, Daniel J. DeAngelo, Daniel J. Weisdorf

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

    Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity? by Ulrike Bacher, Evgeny Klyuchnikov, Jennifer Le‐Rademacher, Jeanette Carreras, Philippe Armand, Michael Bishop, Christopher Bredeson, Mitchell S. Cairo, Timothy S. Fenske, César O. Freytes, Robert Peter Gale, John Gibson, Luis Isola, David J. Inwards, Ginna G. Laport, Hillard M. Lazarus, Richard T. Maziarz, Peter H. Wiernik, Harry C. Schouten, Shimon Slavin, Sonali M. Smith, Julie M. Vose, Edmund K. Waller, Parameswaran Hari

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis

    Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis by Shaji Kumar, Mei-Jie Zhang, Peigang Li, Angela Dispenzieri, Giuseppe Milone, Sagar Lonial, Amrita Krishnan, Ângelo Maiolino, Baldeep Wirk, Brendan M. Weiss, César O. Freytes, Dan T. Vogl, David H. Vesole, Hillard M. Lazarus, Kenneth R. Meehan, Mehdi Hamadani, Michael Lill, Natalie S. Callander, Navneet S. Majhail, Peter H. Wiernik, Rajneesh Nath, Rammurti T. Kamble, Ravi Vij, Robert A. Kyle, Robert Peter Gale, Parameswaran Hari

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma

    Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma by Luciano J. Costa, Mei-Jie Zhang, Xiaobo Zhong, Angela Dispenzieri, Sagar Lonial, Amrita Krishnan, César O. Freytes, David H. Vesole, Robert Peter Gale, Kenneth C. Anderson, Baldeep Wirk, Bipin N. Savani, Edmund K. Waller, Harry C. Schouten, Hillard M. Lazarus, Kenneth R. Meehan, Manish Sharma, Rammurti T. Kamble, Ravi Vij, Shaji Kumar, Taiga Nishihori, Tamila L. Kindwall‐Keller, Wael Saber, Parameswaran Hari

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma

    Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma by Ayman Saad, Anuj Mahindra, Mei-Jie Zhang, Xiaobo Zhong, Luciano J. Costa, Angela Dispenzieri, William R. Drobyski, César O. Freytes, Robert Peter Gale, Cristina Gasparetto, Leona Holmberg, Rammurti T. Kamble, Amrita Krishnan, Robert A. Kyle, David I. Marks, Taiga Nishihori, Marcelo C. Pasquini, Muthalagu Ramanathan, Sagar Lonial, Bipin N. Savani, Wael Saber, Manish Sharma, Mohamed L. Sorror, Baldeep Wirk, Parameswaran Hari

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: